TKP-1002

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTKP-1002
Drug Alias Nameantipsychotics (Talisker Pharma)antipsychotics (University of Liege)antipsychotics (EUSA Pharma)TKP-1002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D4 receptor antagonists
TargetsDopamine D4 receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of Liege
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of LiegeTalisker PharmaEUSA Pharma (USA) Inc
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A